We provide clinically tested safe and effective alternative natural medicines.
What can our medicine do for you?
The health benefits of Fulvic Acid, the main ingredient in Secomet, have been known for thousands of years by traditional healers in many cultures - African, Indian and Chinese amongst others. Tests worldwide has shown that CHD-FA is anti-viral, anti-bacterial, anti-fungal and anti-inflammatory. Visit www.fulhold.com for scientific work on CHD-FA.
What is Fulvic Acid?
Fulvic Acid is known as “Nature’s Miracle Molecule”. In nature it is formed by the natural degradation of plants. Plants recycle Fulvic Acid, taking it from the soil and using it to enhance their uptake of other nutrients. This is particularly the case in wild areas where there has been little disturbance of natural cycles. These are the places where Traditional Healers source many of their ingredients. All plants have, along with their other active ingredients, minute quantities of the miracle molecule - Fulvic Acid. The problem lies in the fact that modern farming methods deprive us of the fulvic acid that nature should provide us with.
Why is our product better than the rest?
Fulvic Acid is mined by many but the problem is that it is contaminated with harmful heavy metals. Secomet has as active ingredient Carbohydrate Derived Fulvic Acid (CHD-FA) free from heavy metals. Through a process called wet oxidation the process of nature is speeded up under high pressure and elevated temperature to produce CHD-FA that is pure, concentrated and can be delivered in measured doses.
Is it safe and tested/researched?
There is already a large body of in-vitro, in-vivo and human clinical trial evidence to support the safety and efficacy of CHD-FA. This has come from top research institutions in the UK, Europe, the US and South Africa. Patient records are meticulously kept for all the human trial work and are available for inspection. Work done include:
- Safety studies in rats.
- Bioavailability in rats.
- Wound healing.
- Safety in humans.
- Non allergic.
- Ames and micronucleaous.
- Anti-inflammatory effectiveness in humans.
Secomet's News
Observational HIV/AIDS trial (Completed successfully 2009).
After approval by the Ethics Committee of a reputable tertiary institution an Observational Study in HIV positive patients using Secomet V was conducted over four months and the effect of the product on the patients was monitored by medical professionals. The reports conclusion is as follows:
- It can therefore be concluded that Secomet V is well tolerated in patients suffering from HIV.
- Secomet V caused no liver or renal toxicity in these patients.
- Secomet V caused a statistically significant reduction of the viral loads of the pre-ART HIV positive patients. This effect needs further extrapolation in a randomized, double blind, controlled study.
- The pre- ART HIV patients on Secomet V reported a significant improvement of their well being proving the HA hypothesis that Secomet V does improve health related outcomes in patients with HIV.
- This study therefore supports further investigations into these effects in a more robust and interventional manner in order to test the validity of The Product as a possible complementary product to boost well being in HIV patients.